Other mentioned targets, such as PFKL, NDUFS3, DENR, TUBB4B, EXOSC10, RPL37a, RPS7, and RPS23, had no prior literature links to CRC and may be considered as novel diagnostic markers or therapeutic targets of CRC (Table 1). This evidence concerns the gene RPS23 and colorectal carcinoma.